跳至主要内容
临床试验/NCT04004390
NCT04004390已完成不适用

Treatment of Post-poliomyelitis Syndrome by Intravenous Immunoglobulin: a Retrospective Study of Efficacy on Clinical and Isokinetic Criteria

University Hospital, Montpellier1 个研究点 分布在 1 个国家目标入组 17 人开始时间: 2019年6月28日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
17
试验地点
1
主要终点
Muscular strength

研究概览

简要总结

Our study evaluates the efficacy of IGIV treatment in PPS on clinical (walking and pain) and isokinetic (muscle strength) criteria, on patients with PS at Montpellier's Hospital

详细描述

Patients are admitted to a multidisciplinary consultation (neurologist, PMK) to validate the indication of treatment with IGIV. Realization of a pre-therapeutic evaluation in the department of MPR on the criteria of judgment, then the patient is admitted in a service of neurology to benefit from the cure of IGIV. The patient is then re-admitted to a PMR service for post-treatment evaluation.

Collection of data retrospectively.

研究设计

研究类型
Observational
观察模型
Other
时间视角
Retrospective

入排标准

年龄范围
30 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Diagnosis of PPS
  • Pre- and post-therapeutic evaluation carried out
  • Data transcribed in the computerized patient file

排除标准

  • No walking patient

结局指标

主要结局

Muscular strength

时间窗: 5 months

Muscular strength with isokinetic

次要结局

  • Walking perimeter(5 months)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验